Making the case for adapting the abbreviated burn severity index to include erythroblast count.
The presence of erythroblasts is an accurate predictor of a poor prognosis. This study investigates whether this should be taken into account when assessing patients with burn injuries as traditional protocols may underestimate the level of risk.
Stachon
A
A
I Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Bochum, Germany. Axel.Stachon@bergmannsheil.de
Lehnhardt
M
M
Katzy
Y
Y
Holland-Letz
T
T
Steinau
H U
HU
Krieg
M
M
D000328:Adult; D002056:Burns / Q000097:blood* / Q000145:classification / Q000175:diagnosis*; D002985:Clinical Protocols; D004900:Erythroblasts / Q000473:pathology*; D004906:Erythrocyte Count; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies; D018570:Risk Assessment / Q000379:methods; D016019:Survival Analysis; D015599:Trauma Severity Indices